Rothfuss Cristin (CIK 0002046214)

Latest company ownership

SRPT - Sarepta Therapeutics, Inc.

Role: EVP, General Counsel

Shares held

139,756

Last filed at

Dec 2, 2025

Confidence Score

52.1

2025Q4

Confidence Score History

2025Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 28, 2025	Dec 2, 2025	Sarepta Therapeutics, Inc.	EVP, General Counsel	Sell	52.5	-229	-0.16%	✗	$4.8K
Mar 10, 2025	Mar 11, 2025	Sarepta Therapeutics, Inc.	EVP, General Counsel	Sell	91.3	+7,785	58.42%	✗	$49.2K
Mar 7, 2025	Mar 10, 2025	Sarepta Therapeutics, Inc.	EVP, General Counsel	Sell	42.5	-1,478	-11.09%	✗	$153.3K
Mar 4, 2025	Mar 6, 2025	Sarepta Therapeutics, Inc.	EVP, General Counsel	Sell	42.5	-584	-2.17%	✗	$59.2K
Mar 3, 2025	Mar 4, 2025	Sarepta Therapeutics, Inc.	EVP, General Counsel	Sell	46.3	-391	-2.79%	✗	$40.6K